ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Oncolytic Virus Therapy Market Report & Forecast 2023-2029
Published Date: November 2023
|
Report Code: QYRE-Auto-22D15601
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global and India Oncolytic Virus Therapy Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Oncolytic Virus Therapy Market Report & Forecast 2023-2029

Code: QYRE-Auto-22D15601
Report
November 2023
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amgen Inc
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys

and India Oncolytic Virus Therapy Market Size

The global Oncolytic Virus Therapy revenue was US$ 6 million in 2022 and is forecast to a readjusted size of US$ 29 million by 2029 with a CAGR of 24.9% during the review period (2023-2029).

and India Oncolytic Virus Therapy Market

and India Oncolytic Virus Therapy Market

Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
In India, the Oncolytic Virus Therapy revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period 2023-2029.
Amgen, Colytics Biotech, Iralytics and Ransgene SA are the leading providers of oncolytic virus therapy, with the first 3 accounting for about 60% of the market.
North America and Europe are the main markets, each accounting for about 40% of the market.
This report focuses on global and India Oncolytic Virus Therapy market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Oncolytic Virus Therapy will continue to grow rapidly in the future.
Global Oncolytic Virus Therapy Scope and Market Size
Oncolytic Virus Therapy market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Oncolytic Virus Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.
For India market, this report focuses on the Oncolytic Virus Therapy market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Oncolytic Virus Therapy Market Report

Report Metric Details
Report Name and India Oncolytic Virus Therapy Market
Forecasted market size in 2029 US$ 29 million
CAGR 24.9%
Forecasted years 2023 - 2029
Segment by Type
  • HSV-based Oncolytic Viruses
  • Adenoviruses-based Oncolytic Viruses
  • Vaccinia Virus-based Oncolytic Viruses
  • Vesicular Stomatitis Virus-based Oncolytic Viruses
  • Newcastle Disease Virus-based Oncolytic Viruses
Segment by Application
  • Melanoma
  • Prostate Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics, Cold Genesys
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Oncolytic Virus Therapy Market size in 2029?

Ans: The and India Oncolytic Virus Therapy Market size in 2029 will be US$ 29 million.

What is the Amgen share in and India Oncolytic Virus Therapy Market?

Ans: Amgen, Colytics Biotech, Iralytics and Ransgene SA are the leading providers of oncolytic virus therapy, with the first 3 accounting for about 60% of the market.

What is the and India Oncolytic Virus Therapy Market share by region?

Ans: North America and Europe are the main markets, each accounting for about 40% of the market. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Oncolytic Virus Therapy Market report?

Ans: The main players in the and India Oncolytic Virus Therapy Market are Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics, Cold Genesys

What are the Application segmentation covered in the and India Oncolytic Virus Therapy Market report?

Ans: The Applications covered in the and India Oncolytic Virus Therapy Market report are Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, Others

What are the Type segmentation covered in the and India Oncolytic Virus Therapy Market report?

Ans: The Types covered in the and India Oncolytic Virus Therapy Market report are HSV-based Oncolytic Viruses, Adenoviruses-based Oncolytic Viruses, Vaccinia Virus-based Oncolytic Viruses, Vesicular Stomatitis Virus-based Oncolytic Viruses, Newcastle Disease Virus-based Oncolytic Viruses

1 Study Coverage
1.1 Oncolytic Virus Therapy Product Introduction
1.2 Global Oncolytic Virus Therapy Outlook 2018 VS 2022 VS 2029
1.2.1 Global Oncolytic Virus Therapy Market Size for the Year 2018-2029
1.2.2 India Oncolytic Virus Therapy Market Size for the Year 2018-2029
1.3 Oncolytic Virus Therapy Market Size, India VS Global, 2018 VS 2022 VS 2029
1.3.1 The Market Share of India Oncolytic Virus Therapy in Global, 2018 VS 2022 VS 2029
1.3.2 The Growth Rate of Oncolytic Virus Therapy Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4 Oncolytic Virus Therapy Market Dynamics
1.4.1 Oncolytic Virus Therapy Industry Trends
1.4.2 Oncolytic Virus Therapy Market Drivers
1.4.3 Oncolytic Virus Therapy Market Challenges
1.4.4 Oncolytic Virus Therapy Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Oncolytic Virus Therapy by Type
2.1 Oncolytic Virus Therapy Market Segment by Type
2.1.1 HSV-based Oncolytic Viruses
2.1.2 Adenoviruses-based Oncolytic Viruses
2.1.3 Vaccinia Virus-based Oncolytic Viruses
2.1.4 Vesicular Stomatitis Virus-based Oncolytic Viruses
2.1.5 Newcastle Disease Virus-based Oncolytic Viruses
2.2 Global Oncolytic Virus Therapy Market Size by Type (2018, 2022 & 2029)
2.3 Global Oncolytic Virus Therapy Market Size by Type (2018-2029)
2.4 India Oncolytic Virus Therapy Market Size by Type (2018, 2022 & 2029)
2.5 India Oncolytic Virus Therapy Market Size by Type (2018-2029)
3 Oncolytic Virus Therapy by Application
3.1 Oncolytic Virus Therapy Market Segment by Application
3.1.1 Melanoma
3.1.2 Prostate Cancer
3.1.3 Breast Cancer
3.1.4 Ovarian Cancer
3.1.5 Others
3.2 Global Oncolytic Virus Therapy Market Size by Application (2018, 2022 & 2029)
3.3 Global Oncolytic Virus Therapy Market Size by Application (2018-2029)
3.4 India Oncolytic Virus Therapy Market Size by Application (2018, 2022 & 2029)
3.5 India Oncolytic Virus Therapy Market Size by Application (2018-2029)
4 Global Oncolytic Virus Therapy Competitor Landscape by Company
4.1 Global Oncolytic Virus Therapy Market Size by Company
4.1.1 Global Key Companies of Oncolytic Virus Therapy, Ranked by Revenue (2022)
4.1.2 Global Oncolytic Virus Therapy Revenue by Player (2018-2023)
4.2 Global Oncolytic Virus Therapy Concentration Ratio (CR)
4.2.1 Oncolytic Virus Therapy Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Oncolytic Virus Therapy in 2022
4.2.3 Global Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Oncolytic Virus Therapy Head office and Area Served
4.4 Global Key Players of Oncolytic Virus Therapy, Product and Application
4.5 Global Key Players of Oncolytic Virus Therapy, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Oncolytic Virus Therapy Market Size by Company
4.7.1 Key Players of Oncolytic Virus Therapy in India, Ranked by Revenue (2022)
4.7.2 India Oncolytic Virus Therapy Revenue by Players (2021, 2022 & 2023)
5 Global Oncolytic Virus Therapy Market Size by Region
5.1 Global Oncolytic Virus Therapy Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Oncolytic Virus Therapy Market Size by Region (2018-2029)
5.2.1 Global Oncolytic Virus Therapy Market Size by Region: 2018-2023
5.2.2 Global Oncolytic Virus Therapy Market Size by Region (2024-2029)
6 Americas
6.1 Americas Oncolytic Virus Therapy Market Size YoY Growth 2018-2029
6.2 Americas Oncolytic Virus Therapy Market Size by Type
6.2.1 Americas Oncolytic Virus Therapy Market Size by Type (2018-2023)
6.2.2 Americas Oncolytic Virus Therapy Market Size by Type (2024-2029)
6.2.3 Americas Oncolytic Virus Therapy Market Share by Type (2018-2029)
6.3 Americas Oncolytic Virus Therapy Market Size by Application
6.3.1 Americas Oncolytic Virus Therapy Market Size by Application (2018-2023)
6.3.2 Americas Oncolytic Virus Therapy Market Size by Application (2024-2029)
6.3.3 Americas Oncolytic Virus Therapy Market Share by Application (2018-2029)
6.4 Americas Oncolytic Virus Therapy Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Oncolytic Virus Therapy Market Size YoY Growth 2018-2029
7.2 EMEA Oncolytic Virus Therapy Market Size by Type
7.2.1 EMEA Oncolytic Virus Therapy Market Size by Type (2018-2023)
7.2.2 EMEA Oncolytic Virus Therapy Market Size by Type (2024-2029)
7.2.3 EMEA Oncolytic Virus Therapy Market Share by Type (2018-2029)
7.3 EMEA Oncolytic Virus Therapy Market Size by Application
7.3.1 EMEA Oncolytic Virus Therapy Market Size by Application (2018-2023)
7.3.2 EMEA Oncolytic Virus Therapy Market Size by Application (2024-2029)
7.3.3 EMEA Oncolytic Virus Therapy Market Share by Application (2018-2029)
7.4 EMEA Oncolytic Virus Therapy Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Oncolytic Virus Therapy Market Size YoY Growth 2018-2029
8.2 China Oncolytic Virus Therapy Market Size by Type
8.2.1 China Oncolytic Virus Therapy Market Size by Type (2018-2023)
8.2.2 China Oncolytic Virus Therapy Market Size by Type (2024-2029)
8.2.3 China Oncolytic Virus Therapy Market Share by Type (2018-2029)
8.3 China Oncolytic Virus Therapy Market Size by Application
8.3.1 China Oncolytic Virus Therapy Market Size by Application (2018-2023)
8.3.2 China Oncolytic Virus Therapy Market Size by Application (2024-2029)
8.3.3 China Oncolytic Virus Therapy Market Share by Application (2018-2029)
9 APAC (excluding China)
9.1 APAC Oncolytic Virus Therapy Market Size YoY Growth 2018-2029
9.2 APAC Oncolytic Virus Therapy Market Size by Type
9.2.1 APAC Oncolytic Virus Therapy Market Size by Type (2018-2023)
9.2.2 APAC Oncolytic Virus Therapy Market Size by Type (2024-2029)
9.2.3 APAC Oncolytic Virus Therapy Market Share by Type (2018-2029)
9.3 APAC Oncolytic Virus Therapy Market Size by Application
9.3.1 APAC Oncolytic Virus Therapy Market Size by Application (2018-2023)
9.3.2 APAC Oncolytic Virus Therapy Market Size by Application (2024-2029)
9.3.3 APAC Oncolytic Virus Therapy Market Share by Application (2018-2029)
9.4 APAC Oncolytic Virus Therapy Market Facts & Figures by Country (2018, 2022 & 2029)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Amgen
10.1.1 Amgen Company Details
10.1.2 Amgen Business Overview
10.1.3 Amgen Oncolytic Virus Therapy Introduction
10.1.4 Amgen Revenue in Oncolytic Virus Therapy Business (2018-2023)
10.1.5 Amgen Recent Development
10.2 Oncolytics Biotech
10.2.1 Oncolytics Biotech Company Details
10.2.2 Oncolytics Biotech Business Overview
10.2.3 Oncolytics Biotech Oncolytic Virus Therapy Introduction
10.2.4 Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2018-2023)
10.2.5 Oncolytics Biotech Recent Development
10.3 Viralytics
10.3.1 Viralytics Company Details
10.3.2 Viralytics Business Overview
10.3.3 Viralytics Oncolytic Virus Therapy Introduction
10.3.4 Viralytics Revenue in Oncolytic Virus Therapy Business (2018-2023)
10.3.5 Viralytics Recent Development
10.4 Transgene SA
10.4.1 Transgene SA Company Details
10.4.2 Transgene SA Business Overview
10.4.3 Transgene SA Oncolytic Virus Therapy Introduction
10.4.4 Transgene SA Revenue in Oncolytic Virus Therapy Business (2018-2023)
10.4.5 Transgene SA Recent Development
10.5 Oncolys BioPharma
10.5.1 Oncolys BioPharma Company Details
10.5.2 Oncolys BioPharma Business Overview
10.5.3 Oncolys BioPharma Oncolytic Virus Therapy Introduction
10.5.4 Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2018-2023)
10.5.5 Oncolys BioPharma Recent Development
10.6 Targovax
10.6.1 Targovax Company Details
10.6.2 Targovax Business Overview
10.6.3 Targovax Oncolytic Virus Therapy Introduction
10.6.4 Targovax Revenue in Oncolytic Virus Therapy Business (2018-2023)
10.6.5 Targovax Recent Development
10.7 PsiOxus Therapeutics
10.7.1 PsiOxus Therapeutics Company Details
10.7.2 PsiOxus Therapeutics Business Overview
10.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Introduction
10.7.4 PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2018-2023)
10.7.5 PsiOxus Therapeutics Recent Development
10.8 SillaJen Biotherapeutics
10.8.1 SillaJen Biotherapeutics Company Details
10.8.2 SillaJen Biotherapeutics Business Overview
10.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Introduction
10.8.4 SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2018-2023)
10.8.5 SillaJen Biotherapeutics Recent Development
10.9 Sorrento Therapeutics
10.9.1 Sorrento Therapeutics Company Details
10.9.2 Sorrento Therapeutics Business Overview
10.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Introduction
10.9.4 Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2018-2023)
10.9.5 Sorrento Therapeutics Recent Development
10.10 Lokon Pharma
10.10.1 Lokon Pharma Company Details
10.10.2 Lokon Pharma Business Overview
10.10.3 Lokon Pharma Oncolytic Virus Therapy Introduction
10.10.4 Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2018-2023)
10.10.5 Lokon Pharma Recent Development
10.11 Genelux Corporation
10.11.1 Genelux Corporation Company Details
10.11.2 Genelux Corporation Business Overview
10.11.3 Genelux Corporation Oncolytic Virus Therapy Introduction
10.11.4 Genelux Corporation Revenue in Oncolytic Virus Therapy Business (2018-2023)
10.11.5 Genelux Corporation Recent Development
10.12 Vyriad
10.12.1 Vyriad Company Details
10.12.2 Vyriad Business Overview
10.12.3 Vyriad Oncolytic Virus Therapy Introduction
10.12.4 Vyriad Revenue in Oncolytic Virus Therapy Business (2018-2023)
10.12.5 Vyriad Recent Development
10.13 TILT Biotherapeutics
10.13.1 TILT Biotherapeutics Company Details
10.13.2 TILT Biotherapeutics Business Overview
10.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Introduction
10.13.4 TILT Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2018-2023)
10.13.5 TILT Biotherapeutics Recent Development
10.14 Cold Genesys
10.14.1 Cold Genesys Company Details
10.14.2 Cold Genesys Business Overview
10.14.3 Cold Genesys Oncolytic Virus Therapy Introduction
10.14.4 Cold Genesys Revenue in Oncolytic Virus Therapy Business (2018-2023)
10.14.5 Cold Genesys Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
FEATURED COMPANIES
Amgen Inc
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys
List of Tables
    Table 1. Oncolytic Virus Therapy Market Size India VS Global, CAGR (2018 VS 2022 VS 2029)
    Table 2. Oncolytic Virus Therapy Market Trends
    Table 3. Oncolytic Virus Therapy Market Drivers
    Table 4. Oncolytic Virus Therapy Market Challenges
    Table 5. Oncolytic Virus Therapy Market Restraints
    Table 6. Global Oncolytic Virus Therapy Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Oncolytic Virus Therapy Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Oncolytic Virus Therapy Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Oncolytic Virus Therapy Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Companies of Oncolytic Virus Therapy, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Oncolytic Virus Therapy Revenue by Player, (US$ Million), 2018-2023
    Table 12. Global Oncolytic Virus Therapy Revenue Share by Player, 2018-2023
    Table 13. Global Oncolytic Virus Therapy Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Oncolytic Virus Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Therapy as of 2022)
    Table 15. Global Key Players of Oncolytic Virus Therapy, Headquarters and Area Served
    Table 16. Global Key Players of Oncolytic Virus Therapy, Product and Application
    Table 17. Global Key Players of Oncolytic Virus Therapy, Date of Enter into This Industry
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Key Players of Oncolytic Virus Therapy in India, Ranked by Revenue (2022) & (US$ Million)
    Table 20. India Oncolytic Virus Therapy Revenue by Players, (US$ Million), 2021, 2022 & 2023
    Table 21. India Oncolytic Virus Therapy Revenue Share by Players, 2021, 2022 & 2023
    Table 22. Global Oncolytic Virus Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 23. Global Oncolytic Virus Therapy Market Size by Region (2018-2023) & (US$ Million)
    Table 24. Global Oncolytic Virus Therapy Market Size Forecast by Region (2024-2029) & (US$ Million)
    Table 25. Americas Oncolytic Virus Therapy Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Americas Oncolytic Virus Therapy Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Americas Oncolytic Virus Therapy Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Americas Oncolytic Virus Therapy Market Size by Application (2024-2029) & (US$ Million)
    Table 29. Americas Oncolytic Virus Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 30. Americas Oncolytic Virus Therapy Market Size by Country (2018-2023) & (US$ Million)
    Table 31. Americas Oncolytic Virus Therapy Market Size by Country (2024-2029) & (US$ Million)
    Table 32. EMEA Oncolytic Virus Therapy Market Size by Type (2018-2023) & (US$ Million)
    Table 33. EMEA Oncolytic Virus Therapy Market Size by Type (2024-2029) & (US$ Million)
    Table 34. EMEA Oncolytic Virus Therapy Market Size by Application (2018-2023) & (US$ Million)
    Table 35. EMEA Oncolytic Virus Therapy Market Size by Application (2024-2029) & (US$ Million)
    Table 36. EMEA Oncolytic Virus Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. EMEA Oncolytic Virus Therapy Market Size by Country (2018-2023) & (US$ Million)
    Table 38. EMEA Oncolytic Virus Therapy Market Size by Country (2024-2029) & (US$ Million)
    Table 39. China Oncolytic Virus Therapy Market Size by Type (2018-2023) & (US$ Million)
    Table 40. China Oncolytic Virus Therapy Market Size by Type (2024-2029) & (US$ Million)
    Table 41. China Oncolytic Virus Therapy Market Size by Application (2018-2023) & (US$ Million)
    Table 42. China Oncolytic Virus Therapy Market Size by Application (2024-2029) & (US$ Million)
    Table 43. China Oncolytic Virus Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. APAC Oncolytic Virus Therapy Market Size by Type (2018-2023) & (US$ Million)
    Table 45. APAC Oncolytic Virus Therapy Market Size by Type (2024-2029) & (US$ Million)
    Table 46. APAC Oncolytic Virus Therapy Market Size by Application (2018-2023) & (US$ Million)
    Table 47. APAC Oncolytic Virus Therapy Market Size by Application (2024-2029) & (US$ Million)
    Table 48. APAC Oncolytic Virus Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 49. APAC Oncolytic Virus Therapy Market Size by Region (2018-2023) & (US$ Million)
    Table 50. APAC Oncolytic Virus Therapy Market Size by Region (2024-2029) & (US$ Million)
    Table 51. Amgen Company Details
    Table 52. Amgen Business Overview
    Table 53. Amgen Oncolytic Virus Therapy Product
    Table 54. Amgen Revenue in Oncolytic Virus Therapy Business (2018-2023) & (US$ Million)
    Table 55. Amgen Recent Development
    Table 56. Oncolytics Biotech Company Details
    Table 57. Oncolytics Biotech Business Overview
    Table 58. Oncolytics Biotech Oncolytic Virus Therapy Product
    Table 59. Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2018-2023) & (US$ Million)
    Table 60. Oncolytics Biotech Recent Development
    Table 61. Viralytics Company Details
    Table 62. Viralytics Business Overview
    Table 63. Viralytics Oncolytic Virus Therapy Product
    Table 64. Viralytics Revenue in Oncolytic Virus Therapy Business (2018-2023) & (US$ Million)
    Table 65. Viralytics Recent Development
    Table 66. Transgene SA Company Details
    Table 67. Transgene SA Business Overview
    Table 68. Transgene SA Oncolytic Virus Therapy Product
    Table 69. Transgene SA Revenue in Oncolytic Virus Therapy Business (2018-2023) & (US$ Million)
    Table 70. Transgene SA Recent Development
    Table 71. Oncolys BioPharma Company Details
    Table 72. Oncolys BioPharma Business Overview
    Table 73. Oncolys BioPharma Oncolytic Virus Therapy Product
    Table 74. Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2018-2023) & (US$ Million)
    Table 75. Oncolys BioPharma Recent Development
    Table 76. Targovax Company Details
    Table 77. Targovax Business Overview
    Table 78. Targovax Oncolytic Virus Therapy Product
    Table 79. Targovax Revenue in Oncolytic Virus Therapy Business (2018-2023) & (US$ Million)
    Table 80. Targovax Recent Development
    Table 81. PsiOxus Therapeutics Company Details
    Table 82. PsiOxus Therapeutics Business Overview
    Table 83. PsiOxus Therapeutics Oncolytic Virus Therapy Product
    Table 84. PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2018-2023) & (US$ Million)
    Table 85. PsiOxus Therapeutics Recent Development
    Table 86. SillaJen Biotherapeutics Company Details
    Table 87. SillaJen Biotherapeutics Business Overview
    Table 88. SillaJen Biotherapeutics Oncolytic Virus Therapy Product
    Table 89. SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2018-2023) & (US$ Million)
    Table 90. SillaJen Biotherapeutics Recent Development
    Table 91. Sorrento Therapeutics Company Details
    Table 92. Sorrento Therapeutics Business Overview
    Table 93. Sorrento Therapeutics Oncolytic Virus Therapy Product
    Table 94. Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2018-2023) & (US$ Million)
    Table 95. Sorrento Therapeutics Recent Development
    Table 96. Lokon Pharma Company Details
    Table 97. Lokon Pharma Business Overview
    Table 98. Lokon Pharma Oncolytic Virus Therapy Product
    Table 99. Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2018-2023) & (US$ Million)
    Table 100. Lokon Pharma Recent Development
    Table 101. Genelux Corporation Company Details
    Table 102. Genelux Corporation Business Overview
    Table 103. Genelux Corporation Oncolytic Virus Therapy Product
    Table 104. Genelux Corporation Revenue in Oncolytic Virus Therapy Business (2018-2023) & (US$ Million)
    Table 105. Genelux Corporation Recent Development
    Table 106. Vyriad Company Details
    Table 107. Vyriad Business Overview
    Table 108. Vyriad Oncolytic Virus Therapy Product
    Table 109. Vyriad Revenue in Oncolytic Virus Therapy Business (2018-2023) & (US$ Million)
    Table 110. Vyriad Recent Development
    Table 111. TILT Biotherapeutics Company Details
    Table 112. TILT Biotherapeutics Business Overview
    Table 113. TILT Biotherapeutics Oncolytic Virus Therapy Product
    Table 114. TILT Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2018-2023) & (US$ Million)
    Table 115. TILT Biotherapeutics Recent Development
    Table 116. Cold Genesys Company Details
    Table 117. Cold Genesys Business Overview
    Table 118. Cold Genesys Oncolytic Virus Therapy Product
    Table 119. Cold Genesys Revenue in Oncolytic Virus Therapy Business (2018-2023) & (US$ Million)
    Table 120. Cold Genesys Recent Development
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oncolytic Virus Therapy Product Picture
    Figure 2. Global Oncolytic Virus Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Oncolytic Virus Therapy Market Size 2018-2029 (US$ Million)
    Figure 4. India Oncolytic Virus Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 5. India Oncolytic Virus Therapy Market Size 2018-2029 (US$ Million)
    Figure 6. India Oncolytic Virus Therapy Market Share in Global 2018-2029
    Figure 7. Oncolytic Virus Therapy Report Years Considered
    Figure 8. Product Picture of HSV-based Oncolytic Viruses
    Figure 9. Product Picture of Adenoviruses-based Oncolytic Viruses
    Figure 10. Product Picture of Vaccinia Virus-based Oncolytic Viruses
    Figure 11. Product Picture of Vesicular Stomatitis Virus-based Oncolytic Viruses
    Figure 12. Product Picture of Newcastle Disease Virus-based Oncolytic Viruses
    Figure 13. Global Oncolytic Virus Therapy Market Share by Type in 2022 & 2029
    Figure 14. Global Oncolytic Virus Therapy Market Size by Type (2018-2029) & (US$ Million)
    Figure 15. Global Oncolytic Virus Therapy Market Share by Type (2018-2029)
    Figure 16. India Oncolytic Virus Therapy Market Share by Type in 2022 & 2029
    Figure 17. India Oncolytic Virus Therapy Market Size by Type (2018-2029) & (US$ Million)
    Figure 18. India Oncolytic Virus Therapy Market Share by Type (2018-2029)
    Figure 19. Product Picture of Melanoma
    Figure 20. Product Picture of Prostate Cancer
    Figure 21. Product Picture of Breast Cancer
    Figure 22. Product Picture of Ovarian Cancer
    Figure 23. Product Picture of Others
    Figure 24. Global Oncolytic Virus Therapy Market Share by Application in 2022 & 2029
    Figure 25. Global Oncolytic Virus Therapy Market Size by Application (2018-2029) & (US$ Million)
    Figure 26. Global Oncolytic Virus Therapy Market Share by Application (2018-2029)
    Figure 27. India Oncolytic Virus Therapy Market Share by Application in 2022 & 2029
    Figure 28. India Oncolytic Virus Therapy Market Size by Application (2018-2029) & (US$ Million)
    Figure 29. India Oncolytic Virus Therapy Market Share by Application (2018-2029)
    Figure 30. The Top 5 and 10 Largest Companies of Oncolytic Virus Therapy in the World: Market Share by Oncolytic Virus Therapy Revenue in 2022
    Figure 31. Global Oncolytic Virus Therapy Market Size Market Share by Region: 2018 VS 2022 VS 2029
    Figure 32. Global Oncolytic Virus Therapy Market Share by Region (2018-2029)
    Figure 33. Americas Oncolytic Virus Therapy Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 34. Americas Oncolytic Virus Therapy Market Share by Type (2018-2029)
    Figure 35. Americas Oncolytic Virus Therapy Market Share by Application (2018-2029)
    Figure 36. United States Oncolytic Virus Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 37. Canada Oncolytic Virus Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 38. Mexico Oncolytic Virus Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Brazil Oncolytic Virus Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 40. EMEA Oncolytic Virus Therapy Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 41. EMEA Oncolytic Virus Therapy Market Share by Type (2018-2029)
    Figure 42. EMEA Oncolytic Virus Therapy Market Share by Application (2018-2029)
    Figure 43. Europe Oncolytic Virus Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Middle East Oncolytic Virus Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Africa Oncolytic Virus Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 46. China Oncolytic Virus Therapy Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 47. China Oncolytic Virus Therapy Market Share by Type (2018-2029)
    Figure 48. China Oncolytic Virus Therapy Market Share by Application (2018-2029)
    Figure 49. APAC Oncolytic Virus Therapy Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 50. APAC Oncolytic Virus Therapy Market Share by Type (2018-2029)
    Figure 51. APAC Oncolytic Virus Therapy Market Share by Application (2018-2029)
    Figure 52. Japan Oncolytic Virus Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 53. South Korea Oncolytic Virus Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 54. China Taiwan Oncolytic Virus Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 55. Southeast Asia Oncolytic Virus Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 56. India Oncolytic Virus Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 57. Amgen Revenue Growth Rate in Oncolytic Virus Therapy Business (2018-2023)
    Figure 58. Oncolytics Biotech Revenue Growth Rate in Oncolytic Virus Therapy Business (2018-2023)
    Figure 59. Viralytics Revenue Growth Rate in Oncolytic Virus Therapy Business (2018-2023)
    Figure 60. Transgene SA Revenue Growth Rate in Oncolytic Virus Therapy Business (2018-2023)
    Figure 61. Oncolys BioPharma Revenue Growth Rate in Oncolytic Virus Therapy Business (2018-2023)
    Figure 62. Targovax Revenue Growth Rate in Oncolytic Virus Therapy Business (2018-2023)
    Figure 63. PsiOxus Therapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2018-2023)
    Figure 64. SillaJen Biotherapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2018-2023)
    Figure 65. Sorrento Therapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2018-2023)
    Figure 66. Lokon Pharma Revenue Growth Rate in Oncolytic Virus Therapy Business (2018-2023)
    Figure 67. Genelux Corporation Revenue Growth Rate in Oncolytic Virus Therapy Business (2018-2023)
    Figure 68. Vyriad Revenue Growth Rate in Oncolytic Virus Therapy Business (2018-2023)
    Figure 69. TILT Biotherapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2018-2023)
    Figure 70. Cold Genesys Revenue Growth Rate in Oncolytic Virus Therapy Business (2018-2023)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions